REGENERON PHARMACEUTICALS, INC. Treasury Stock 2013-2026 | REGN
What is treasury stock?
Treasury stock represents shares that were previously issued and later repurchased by the company, reducing total stockholders' equity.
What is REGENERON PHARMACEUTICALS, INC.'s current treasury stock?
REGENERON PHARMACEUTICALS, INC. (REGN) annual treasury stock for 2025 was $18.61B, a 22.72% increase from 2024. REGENERON PHARMACEUTICALS, INC. treasury stock for the quarter ending March 31, 2026 was $19.41B.
What was REGENERON PHARMACEUTICALS, INC.'s treasury stock in 2024?
REGENERON PHARMACEUTICALS, INC. annual treasury stock for 2024 was $15.17B, a 20.76% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s treasury stock in 2023?
REGENERON PHARMACEUTICALS, INC. annual treasury stock for 2023 was $12.56B, a 21.32% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year treasury stock CAGR?
REGENERON PHARMACEUTICALS, INC. treasury stock grew at a compound annual growth rate (CAGR) of 22.99% from FY2020 to FY2025, going from $6.61B to $18.61B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $18.61B | +22.7% | 10-K |
| FY2024 | $15.17B | +20.8% | 10-K |
| FY2023 | $12.56B | +21.3% | 10-K |
| FY2022 | $10.35B | +25.3% | 10-K |
| FY2021 | $8.26B | +24.9% | 10-K |
| FY2020 | $6.61B | +793.8% | 10-K |
| FY2019 | $739.9M | +86.7% | 10-K |
| FY2018 | $396.4M | +25.4% | 10-K |
| FY2017 | $316.2M | -0.0% | 10-K |
| FY2016 | $316.2M | +3.3% | 10-K |
| FY2015 | $306.1M | +80.5% | 10-K |
| FY2014 | $169.5M | - | 10-K |
| FY2013 | $0 | - | 10-K |